Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pasquini

Showing results (121-130 of 228) with videos related to

Pageof 23
Sort By:
Bone Marrow Transplantation|January 4, 2024
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantationSaurabh Chhabra, James H Jerkins, Kathleen Monahan, et al.
American Journal of Hematology|April 13, 2023
Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantationOthmane Jadi, Hancong Tang, Kelly Olsen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studiesMarcelo C Pasquini, Linda M Griffith, Douglas L Arnold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2018
Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release SyndromeRenju V Raj, Mehdi Hamadani, Aniko Szabo, et al.
Blood Advances|May 31, 2018
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabineAndrew C Harris, Jaap J Boelens, Kwang Woo Ahn, et al.
Leukemia|March 17, 2015
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignanciesR F Olsson, B R Logan, S Chaudhury, et al.
Blood|July 19, 2024
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantationLeslie S Kean, Linda J Burns, Tzuyung D Kou, et al.
Haematologica|September 24, 2016
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromesAndrew S Artz, Brent Logan, Xiaochun Zhu, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, H Baldomero, J Szer, et al.
Transplantation and Cellular Therapy|July 15, 2022
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 TrialQaiser Bashir, Taiga Nishihori, Marcelo C Pasquini, et al.
Pageof 23

Showing results (121-130 of 228) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|January 4, 2024
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantationSaurabh Chhabra, James H Jerkins, Kathleen Monahan, et al.
American Journal of Hematology|April 13, 2023
Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantationOthmane Jadi, Hancong Tang, Kelly Olsen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studiesMarcelo C Pasquini, Linda M Griffith, Douglas L Arnold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2018
Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release SyndromeRenju V Raj, Mehdi Hamadani, Aniko Szabo, et al.
Blood Advances|May 31, 2018
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabineAndrew C Harris, Jaap J Boelens, Kwang Woo Ahn, et al.
Leukemia|March 17, 2015
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignanciesR F Olsson, B R Logan, S Chaudhury, et al.
Blood|July 19, 2024
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantationLeslie S Kean, Linda J Burns, Tzuyung D Kou, et al.
Haematologica|September 24, 2016
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromesAndrew S Artz, Brent Logan, Xiaochun Zhu, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, H Baldomero, J Szer, et al.
Transplantation and Cellular Therapy|July 15, 2022
A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 TrialQaiser Bashir, Taiga Nishihori, Marcelo C Pasquini, et al.
Pageof 23